New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a ...

Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure used to replace damaged heart valves, ...

Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...

Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...

The main cause of Gene Hackman's death was heart disease, but he was also in the advanced stages of Alzheimer's disease and ...

The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...

Aortic dissection is a life-threatening medical condition in which a tear occurs in the major artery (aorta) that carries ...

Transcatheter Aortic Valve Implantation (TAVI) allows for the replacement of heart valves to be placed in heart without a major incision and Professor Walton said demand for urgent TAVIs was ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

noting he had experienced congestive heart failure, an aortic valve replacement and an irregular heart beat. He was given a pacemaker in April 2019. Hackman's carbon monoxide concentration was ...

Edwards’ SAPIEN 3 platform becomes the first TAVR system approved by the FDA for asymptomatic severe aortic stenosis patients ...